TSL Express Daily News

Los Angeles, CA -- Anaheim Urgent Care, LLC and affiliates (“UrgentMED” or the “Company”), a leading independent operator of urgent care clinics in Southern California, has received a substantial growth investment from Quilvest Capital Partners (“Quilvest”). Quilvest is partnering with UrgentMED’s co-founders, Dr. Jacob Rastegar, Dr. Morris Kokhab, and Dr. Pejman Bolourian, who will each remain significant shareholders and will continue to lead the business going forward. FocalPoint Partners (“FocalPoint”) served as exclusive financial advisor to the Company.

Founded in 2007 and headquartered in Los Angeles, California, UrgentMED provides a broad range of medical services including examinations, diagnostic testing, non-surgical procedures, occupational health, radiology, specialized care, physical therapy, and COVID-19 testing. UrgentMED’s unique approach to the patient experience combined with its ability to provide a wide array of services has enabled the Company to become a leader in the Southern California healthcare ecosystem with more than 30 locations.

“We are thrilled to partner with Drs. Rastegar, Kokhab, and Bolourian,” said Jay Takefman, Partner and Co-head of Direct Private Equity at Quilvest. “UrgentMED has established itself as the leading independent urgent care network in Southern California. UrgentMED is ideally positioned to meet consumers’ and payors’ demands for convenient, affordable, and high-quality care, deploying its broad healthcare offering across its clinic footprint. We look forward to joining UrgentMED on the next phase of its journey as the Company continues its growth strategy.”

Dr. Jacob Rastegar, Co-founder and Co-CEO, stated, “We welcome the Quilvest team to the UrgentMED family. Quilvest is an ideal partner for us due to its deep understanding of multi-unit business models, healthcare sector expertise, and vast network of resources to help us grow. We are excited to have a supportive partner who shares our vision. FocalPoint’s commitment throughout the process was unparalleled as they utilized their expertise and resources to ensure the outcome was as optimal as possible.”

Nishen Radia, Co-founder and Managing Partner at FocalPoint, said, “We are thrilled to have assisted Drs. Rastegar, Kokhab, and Bolourian, who have built an incredible platform for patient care. Starting in 2017, we worked tirelessly with them to identify and execute on a robust de novo and acquisition program. The onset of COVID-19 radically transformed their industry, and we are proud to secure Quilvest as a partner for them to continue their rapid growth.” 

James Castro, Managing Director and Co-lead of FocalPoint’s Healthcare Group, said, “The urgent care format has transformed the patient experience with greater convenience and access to care. The pandemic accelerated patient adoption of this model which paves the way for primary and specialty care integration. We are pleased that UrgentMED has attracted an innovative partner with which to launch new programs.”

About UrgentMED

UrgentMED opened its first clinic in 2007 with the intent to revolutionize the healthcare industry. Having since grown to 34 locations, the Company’s mission has always revolved around a patient-centered approach in which patients are able to receive superior healthcare in a professional, efficient, and affordable manner. After years of experience, UrgentMED has developed an ideal “one-stop shop” model that allows each individual patient to receive exceptional care in many of the Southern California communities. From professionally trained physicians and staff, to state-of-the-art diagnostic equipment and testing, each of UrgentMED’s clinics are fully equipped to diagnose and treat our patient’s medical needs. As we continue to grow into neighboring communities, our vision is to change the face of healthcare in California. For more information, please visit: https://urgentmednetwork.com.

About Quilvest Capital Partners

Quilvest Capital Partners is the multi-strategy alternatives division of the Quilvest Group. The Quilvest Group was formed in 1917 to manage the holdings of the Bemberg family, the founders of Quilmes Brewery, Argentina’s largest brewery. The Quilvest Group has evolved alongside seven generations of the Bemberg family into a global, multi-family office with $16 billion in assets under management and over a century of experience in wealth management and alternative investing. With approximately $6 billion in assets under management and a global platform spanning North America, Europe, and Asia, Quilvest Capital Partners focuses on partnering with exceptional entrepreneurs to accelerate growth of middle market companies. Quilvest Capital Partners takes majority or influential minority positions in businesses with a strong track record of profitable growth, leveraging the pioneering heritage and innovative spirit that have helped shape the Quilvest Group’s multiple investment platforms over the last century. For more information, please visit: www.quilvestcapitalpartners.com.

About FocalPoint Partners

FocalPoint is an independent investment bank specializing in mergers and acquisitions, private placements (both debt and equity), financial restructurings, and special situation transactions. With offices in Los Angeles, Chicago, New York, and Shanghai, the firm provides financial advisory services to middle market clients and has a dedicated Healthcare practice. Since its inception in 2002, FocalPoint has completed transactions with an aggregate value of more than $16 billion. For more information, please visit https://focalpointllc.com and follow us on LinkedIn and Twitter.

Please contact Nishen Radia, Managing Partner, at 310-405-7040 or Eugene Izumo, Director, at 310-405-7015, for more information regarding this transaction.